"Are we investing enough behind these big growth drivers? We think no. We want to invest more," Medtronic CEO Geoff Martha ...

Medtronic shows mixed results with strong Cardiovascular growth and weaker Neuroscience/MedSurg. Click here to read an ...

Medtronic’s stock price has lagged behind competitors’ for years, with investors weary of the company’s pace of growth. But a ...

“Our decision to become one of Medtronic’s largest investors was driven by our strong conviction that the company is entering ...

Medtronic officials today said that the company's planned separation of its Diabetes business is on the right track.

Medtronic appoints two new board directors following talks with activist investor Elliott Investment Management.

Medtronic has agreed to not only expand the size of its board of directors, but to also task it with taking a closer look at ...

CEO Geoff Martha told investors that the initiatives were done in partnership with the activist investor firm Elliott ...

A clutch of post-earnings price target increases by analysts helped raise Medtronic 's (NYSE: MDT) stock at a healthy rate on ...

The FDA said the request to quarantine the devices followed reports of the products “resisting shape retention when being ...

Medtronic has raised its fiscal year 2026 (FY26) profit outlook to 4.5%, up from a previous target of 4%, amid strong growth ...

The FDA issued an early notice alerting customers of a warning letter issued by Medtronic for certain DLP left heart vent ...